Cytek CTO Yan Ming Offloads 1.18 M Shares in Quiet Liquidity Move, While Execs Keep Buying Stock
Cytek Biosciences’ CTO sells 1.18 M shares—an isolated liquidity move, not a confidence loss—while other executives keep buying, signaling continued insider support.
3 minutes to read
